BNP Paribas Financial Markets Takes $95,000 Position in American Well Co. (NYSE:AMWL)

BNP Paribas Financial Markets purchased a new position in American Well Co. (NYSE:AMWL) during the 3rd quarter, Holdings Channel.com reports. The firm purchased 10,014 shares of the company’s stock, valued at approximately $95,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Point72 DIFC Ltd boosted its holdings in American Well by 1,418.5% in the second quarter. Point72 DIFC Ltd now owns 103,457 shares of the company’s stock worth $34,000 after acquiring an additional 96,644 shares in the last quarter. Cubist Systematic Strategies LLC grew its position in American Well by 7,673.8% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 184,083 shares of the company’s stock valued at $60,000 after purchasing an additional 181,715 shares during the last quarter. Cowen AND Company LLC purchased a new stake in American Well during the 2nd quarter valued at about $81,000. Point72 Asia Singapore Pte. Ltd. increased its stake in American Well by 2,690.2% during the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 419,841 shares of the company’s stock valued at $136,000 after purchasing an additional 404,794 shares in the last quarter. Finally, AQR Capital Management LLC raised its holdings in American Well by 28.1% in the second quarter. AQR Capital Management LLC now owns 1,895,730 shares of the company’s stock worth $616,000 after buying an additional 416,387 shares during the last quarter. Institutional investors own 56.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on AMWL. Needham & Company LLC reissued a “hold” rating on shares of American Well in a research report on Thursday, October 31st. Morgan Stanley cut their target price on American Well from $20.00 to $10.50 and set an “equal weight” rating on the stock in a research note on Tuesday.

American Well Stock Down 7.0 %

Shares of NYSE AMWL opened at $7.86 on Thursday. The firm’s 50-day moving average price is $9.23 and its 200-day moving average price is $8.67. American Well Co. has a 52-week low of $5.00 and a 52-week high of $31.60. The company has a market cap of $120.42 million, a PE ratio of -0.54 and a beta of 1.07.

American Well Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.